LUCC: Lund University Cancer Centre
421 – 430 of 2748
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Register data on long-term morbidity after prostate cancer radiotherapy with ultra-hypofractionated (2.5 weeks) vs conventional (8 weeks) treatment schedules
2024) U21 Health Sciences Group 2024 Doctoral Student Forum(
- Contribution to conference › Poster
-
Mark
Amniotic fluid derived mesenchymal stem cells reduce inflammation and improve lung function following transplantation in a porcine model
2024) In The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation(
- Contribution to journal › Article
-
Mark
Living with the threat of losing a child : Parents' experiences of the transplantation process with a severely ill child who received stem cells from a sibling
(
- Contribution to journal › Article
-
Mark
Anti-Müllerian hormone and fertility in women after childhood cancer treatment : Association with current infertility risk classifications
(
- Contribution to journal › Article
-
Mark
Mammalian cell display with automated oligo design and library assembly allows for rapid residue level conformational epitope mapping
(
- Contribution to journal › Article
-
Mark
Spatial tumor immune microenvironment phenotypes in ovarian cancer
(
- Contribution to journal › Article
-
Mark
ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia
(
- Contribution to journal › Article
-
Mark
The risk for venous thromboembolism and cardiometabolic disorders in offspring from thrombosis-prone pedigrees
2024) In Journal of Thrombosis and Haemostasis(
- Contribution to journal › Article
-
Mark
Parental satisfaction with paediatric care with and without the support of an eHealth device : a quasi-experimental study in Sweden
(
- Contribution to journal › Article
-
Mark
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1) : a multicentre, randomised, phase 2 trial
(
- Contribution to journal › Article